Palogic Value Management’s Cleveland-Cliffs CLF Stock Holding History

Palogic Value Management’s Portfolio CLF Stock Details CLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$156K	–	160
2023 Q3	$156K	Hold	10,000	–	–	0.07%	149
2023 Q2	$168K	Hold	10,000	–	–	0.08%	153
2023 Q1	$183K	Hold	10,000	–	–	0.09%	153
2022 Q4	$161K	Buy	+10,000	New	+$151K	0.08%	146

Other funds holding CLF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Palogic Value Management's CLF Position: Q4 2023 in Review

Palogic Value Management sold out of Cleveland-Cliffs (CLF) in Q4 2023, closing a stake of 10,000 shares — an estimated $156K sold.

Palogic Value Management first reported a position in CLF in Q4 2022 and held it in 4 quarters. The position peaked at $183K in Q1 2023. 624 funds tracked by Wall St. Rank hold CLF as of Q4 2023.

Palogic Value Management reported no remaining Cleveland-Cliffs position as of Q4 2023 after selling out during the quarter.
Palogic Value Management sold 10,000 Cleveland-Cliffs shares in Q4 2023, an estimated $156K.
Palogic Value Management first reported a position in Cleveland-Cliffs in Q4 2022 and held it in 4 quarters.
Palogic Value Management's Cleveland-Cliffs position peaked at $183K in Q1 2023.
624 funds tracked by Wall St. Rank held Cleveland-Cliffs as of Q4 2023.

Based on Palogic Value Management's 13F filing for Q4 2023, filed 14 Feb 2024.